BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2812274)

  • 21. Role of hypothalamic catecholamines in the regulation of luteinizing hormone and prolactin secretion in the ewe during seasonal anestrus.
    Thiéry JC; Martin GB; Tillet Y; Caldani M; Quentin M; Jamain C; Ravault JP
    Neuroendocrinology; 1989 Jan; 49(1):80-7. PubMed ID: 2497396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of hypothalamic GnRH secretion in the ewe by antigonadotropic decapeptide during the estrous cycle and nonbreeding season.
    Lee H; Esquivel E; Wise ME
    Endocrine; 1999 Aug; 11(1):75-82. PubMed ID: 10668645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that changes in the function of the subtypes of the receptors for gamma-amino butyric acid may be involved in the seasonal changes in the negative-feedback effects of estrogen on gonadotropin-releasing hormone secretion and plasma luteinizing hormone levels in the ewe.
    Scott CJ; Clarke IJ
    Endocrinology; 1993 Dec; 133(6):2904-12. PubMed ID: 8243318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that gamma-aminobutyric acid is part of the neural circuit mediating estradiol negative feedback in anestrous ewes.
    Bogusz AL; Hardy SL; Lehman MN; Connors JM; Hileman SM; Sliwowska JH; Billings HJ; McManus CJ; Valent M; Singh SR; Nestor CC; Coolen LM; Goodman RL
    Endocrinology; 2008 Jun; 149(6):2762-72. PubMed ID: 18325998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of prolonged, intracerebroventricular prolactin treatment on luteinizing hormone secretion, catecholaminergic activity and estrous behavior in ewes.
    Misztal T; Romanowicz K; Tomaszewska-Zaremba D; Wójcik-Gładysz A; Barcikowski B
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):215-21. PubMed ID: 15127327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that Dopaminergic Neurons are not Involved in the Negative Feedback Effect of Testosterone on Luteinizing Hormone in Rams in the Non-Breeding Season.
    Tilbrook AJ; Clarke IJ
    J Neuroendocrinol; 1992 Jun; 4(3):365-74. PubMed ID: 21554619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperresponsiveness to the inhibitory action of dopamine agonists on luteinizing hormone secretion in the monosodium-L-glutamate-treated, orchidectomized rat.
    Rose PA; Weick RF
    Neuroendocrinology; 1986; 44(1):95-101. PubMed ID: 3024058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of action of dopamine on the in vitro release of gonadotropin-releasing hormone.
    Jarjour LT; Handelsman DJ; Raum WJ; Swerdloff RS
    Endocrinology; 1986 Oct; 119(4):1726-32. PubMed ID: 3019641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrical stimulation of ascending noradrenergic tracts in the midbrain: suppression of steroid-induced luteinizing hormone release.
    Bergen H; Leung PC
    Endocrinology; 1988 Mar; 122(3):899-905. PubMed ID: 3342757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the inhibitory action of estradiol on luteinizing hormone pulse frequency in anestrous ewes mediated by noradrenergic neurons in the preoptic area?
    Goodman RL; Robinson JE; Kendrick KM; Dyer RG
    Neuroendocrinology; 1995 Mar; 61(3):284-92. PubMed ID: 7898633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for central nervous system (CNS) involvement in inhibition of luteinizing hormone (LH) release by dopamine receptor stimulation.
    Owens RE; Fleeger JL; Harms PG
    Endocr Res Commun; 1980; 7(2):99-105. PubMed ID: 6997016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of luteinizing hormone and prolactin levels in cycling and anestrous ewes.
    Jackson GL; Davis SL
    Neuroendocrinology; 1979; 28(4):256-63. PubMed ID: 571540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a possible role for the dopamine d and d receptors in the steroid-dependent suppression of luteinizing hormone secretion in the seasonally anoestrous ewe.
    Curlewis JD; Naylor AM; McNeilly AS
    J Neuroendocrinol; 1991 Aug; 3(4):387-91. PubMed ID: 19215481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of GABAB receptor modulation on gonadotropin-releasing hormone and beta-endorphin release, and on catecholaminergic activity in the ventromedial hypothalamus-infundibular nucleus region of anoestrous ewes.
    Tomaszewska-Zaremba D; Przekop F
    J Neuroendocrinol; 2005 Jan; 17(1):49-56. PubMed ID: 15720475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects on plasma luteinizing hormone levels of microinjection of noradrenaline and adrenaline into the septo-preoptic area of the brain of the ovariectomized ewe: changes with season and chronic oestrogen treatment.
    Scott CJ; Cumminst JT; Clarke IJ
    J Neuroendocrinol; 1992 Feb; 4(1):131-41. PubMed ID: 21554588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The actions of dopaminergic and noradrenergic antagonists on conditioned avoidance responses in intact and 6-hydroxydopamine-treated rats.
    Taboada ME; Souto M; Hawkins H; Monti JM
    Psychopharmacology (Berl); 1979 Mar; 62(1):83-8. PubMed ID: 108752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular monoamines and their metabolites in the mediobasal hypothalamus--median eminence of anestrous and estrous ewes during CRF treatment.
    Tomaszewska D; Mateusiak K; Przekop F
    Exp Clin Endocrinol Diabetes; 1997; 105(3):175-81. PubMed ID: 9228515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of dopamine on gonadotropin release in female goldfish, Carassius auratus.
    Chang JP; Peter RE
    Neuroendocrinology; 1983 May; 36(5):351-7. PubMed ID: 6343907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of systemic administration of dopamine and apomorphine on Plasma LH and prolactin concentrations in conscious rats.
    Vijayan E; McCann SM
    Neuroendocrinology; 1978; 25(4):221-35. PubMed ID: 349418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of gonadotropin secretion induced by cholecystokinin implants in the medial preoptic area by the dopamine receptor blocker, pimozide, in the rat.
    Hashimoto R; Kimura F
    Neuroendocrinology; 1986; 42(1):32-7. PubMed ID: 3079892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.